Evaluating the mechanism underlying antitumor effect of interleukin 27 on B cells of chronic lymphocytic leukemia patients-Reference-Cited by-同舟云学术

Evaluating the mechanism underlying antitumor effect of interleukin 27 on B cells of chronic lymphocytic leukemia patients

Published:2020-05-07 Issue:12 Volume:235 Page:9424-9431
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Manouchehri‐Doulabi Ehsan¹²³,Abbaspour Somaye¹²,Rostami Shahrbano⁴,Faranoush Mohammad⁵,Ghahramanfard Farahnaz¹²,Pak Fatemeh¹,Barati Mehdi⁶⁷,Kokhaei Parviz¹²⁸,Momtazi‐Borojeni Amir A.⁹¹⁰^ORCID

Affiliation:

1. Faculty of Medicine, Department of Immunology Semnan University of Medical Sciences Semnan Iran

2. Cancer Research Center Semnan University of Medical Sciences Semnan Iran

3. Students Research Committee Semnan University of Medical Sciences Semnan Iran

4. Hematology‐Oncology and Stem Cell Transplantation Tehran University of Medical Sciences Tehran Iran

5. Iran University of Medical Sciences Rasool Akram Complex Medical Center, MAHAK Hospital Tehran Iran

6. Student Research Committee Mashhad University of Medical Sciences Mashhad Iran

7. Department of Immunology, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran

8. Department of Oncology, Cancer Centre Karolinska Karolinska University, Hospital Solna Stockholm Sweden

9. Halal Research Center of IRI, FDA Tehran Iran

10. Department of Medical Biotechnology, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran

Funder

Semnan University

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.29747

Reference25 articles.

1. Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases

2. Apoptosis inducers in chronic lymphocytic leukemia

3. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model

4. Development of Th1-type immune responses requires the type I cytokine receptor TCCR

5. Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia;Haematologica;2023-06-22

2. Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution;Cancers;2023-01-31

3. Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction;Frontiers in Immunology;2022-09-28

4. Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases;Neural Regeneration Research;2022